Neurodegeneration in an animal model of Parkinson’s disease is exacerbated by a high-fat diet

Global Prevalence of Diabetes

Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · see citing works

Use and Abuse of HOMA Modeling

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · see citing works

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works

Oxidative Stress, Glutamate, and Neurodegenerative Disorders

Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · see citing works

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works

Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of <i>Ikkβ</i>

Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884 · see citing works

NF-κB activation by reactive oxygen species: Fifteen years later

Gloire, G., Legrand-Poels, S., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,540 · see citing works

Regulation and Function of IKK and IKK-Related Kinases

Häcker, H., & Karin, M. (2006) · Science s STKE · doi:10.1126/stke.3572006re13 · Cited by 1,269 · see citing works

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

Blum, D. L., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A., Sadoul, R., & Verna, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246 · see citing works

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · see citing works

Obesity and Free Fatty Acids

Boden, G. H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853 · see citing works

Obesity, insulin resistance and diabetes — a worldwide epidemic

Seidell, J. C. (2000) · British Journal Of Nutrition · doi:10.1017/s000711450000088x · Cited by 708 · see citing works

Leptin Regulation of the Mesoaccumbens Dopamine Pathway

Fulton, S., Pissios, P., Manchon, R. P., Stiles, L., Frank, L., Pothos, E. N., Maratos-Flier, E., & Flier, J. S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.006 · Cited by 644 · see citing works

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A., & Stricker, E. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90112-n · Cited by 609 · see citing works

Cognitive impairment following high fat diet consumption is associated with brain inflammation

Pistell, P. J., Morrison, C. D., Gupta, S., Knight, A. G., Keller, J. N., Ingram, D. K., & Bruce‐Keller, A. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.010 · Cited by 594 · see citing works

Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet

Posey, K. A., Clegg, D. J., Printz, R. L., Byun, J., Morton, G. J., Vivekanandan-Giri, A., Pennathur, S., Baskin, D. G., Heinecke, J. W., Woods, S. C., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90377.2008 · Cited by 586 · see citing works

Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 583 · see citing works

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

Beal, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523 · see citing works

Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Bézard, E., Doveró, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B. H., Brotchie, J. M., & Gross, C. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 484 · see citing works

Is dopamine a physiologically relevant mediator of feeding behavior?

Palmiter, R. D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.004 · Cited by 469 · see citing works

Type 2 Diabetes and the Risk of Parkinson's Disease

Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466 · see citing works

Ageing, neurodegeneration and Parkinson's disease

Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430 · see citing works

Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats

Cacho, J., Sevillano, J., de Castro, J., Herrera, E., & Ramos, P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90207.2008 · Cited by 409 · see citing works

Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity

Geiger, B. M., Haburcak, M., Avena, N. M., Moyer, M. C., Hoebel, B. G., & Pothos, E. N. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.007 · Cited by 403 · see citing works

Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?

Thiruchelvam, M. J., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory‐Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324 · see citing works

Glutathione—a review on its role and significance in Parkinson's disease

Martin, H. L., & Teismann, P. (2009) · The FASEB Journal · doi:10.1096/fj.08-125443 · Cited by 314 · see citing works

Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat

Davis, J. F., Tracy, A. L., Schurdak, J. D., Tschöp, M. H., Lipton, J. W., Clegg, D. J., & Benoit, S. C. (2008) · Behavioral Neuroscience · doi:10.1037/a0013111 · Cited by 307 · see citing works

High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling

Morrison, C. D., Pistell, P. J., Ingram, D. K., Johnson, W. D., Liu, Y., Fernandez‐Kim, S. O., White, C. L., Purpera, M. N., Uranga, R. M., Bruce‐Keller, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06865.x · Cited by 291 · see citing works

High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex

ZHANG, X., Dong, F., Ren, J. T., Driscoll, M., & Culver, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.011 · Cited by 280 · see citing works

Dopamine, 6-hydroxydopamine, iron, and dioxygen — their mutual interactions and possible implication in the development of Parkinson's disease

Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K. A., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238 · see citing works

The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

Pressley, J. C., Louis, E. D., Tang, M. ‐., Cote, L. J., Cohen, P. D., Glied, S., & Mayeux, R. P. (2003) · Neurology · doi:10.1212/wnl.60.1.87 · Cited by 229 · see citing works

Heat Treatment Improves Glucose Tolerance and Prevents Skeletal Muscle Insulin Resistance in Rats Fed a High-Fat Diet

Gupte, A. A., Bomhoff, G. L., Swerdlow, R. H., & Geiger, P. C. (2008) · Diabetes · doi:10.2337/db08-1070 · Cited by 227 · see citing works

The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls

Andrew, R., Watson, D. G., Best, S. A., Midgley, J. M., Wenlong, H., & Petty, R. (1993) · Neurochemical Research · doi:10.1007/bf00978370 · Cited by 226 · see citing works

Body mass index and the risk of Parkinson disease

Hu, G., Jousilahti, P., Nissinen, A., Antikainen, R., Kivipelto, M., & Tuomilehto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000247052.18422.e5 · Cited by 203 · see citing works

Obesity and vulnerability of the CNS

Bruce-Keller, A. J., Keller, J. N., & Morrison, C. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.004 · Cited by 200 · see citing works

Heat Shock Protein 27 Association with the IκB Kinase Complex Regulates Tumor Necrosis Factor α-induced NF-κB Activation

Park, K.-J., Gaynor, R. B., & Kwak, Y. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305095200 · Cited by 189 · see citing works

Adult nutrient intake as a risk factor for Parkinson's disease

Johnson, C. C. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.6.1102 · Cited by 173 · see citing works

Midlife adiposity and the future risk of Parkinson’s disease

Abbott, R. D., Ross, G. W., White, L. R., Nelson, J. S., Masaki, K., Tanner, C. M., Curb, J. D., Blanchette, P. L., Popper, J. S., & Petrovitch, H. (2002) · Neurology · doi:10.1212/wnl.59.7.1051 · Cited by 163 · see citing works

Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury

Altar, C. A., Marien, M. R., & Marshall, J. F. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04106.x · Cited by 161 · see citing works

Activation of glucose transport in muscle by prolonged exposure to insulin. Effects of glucose and insulin concentrations.

Young, D. A., Uhl, J. J., Cartee, G. D., & Holloszy, J. O. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66674-8 · Cited by 153 · see citing works

Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus

Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151 · see citing works

Iron, the substantia nigra and related neurological disorders

Snyder, A. M., & Connor, J. R. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.005 · Cited by 137 · see citing works

Iron-Mediated Generation of the Neurotoxin 6-Hydroxydopamine Quinone by Reaction of Fatty Acid Hydroperoxides with Dopamine: A Possible Contributory Mechanism for Neuronal Degeneration in Parkinson's Disease

Pezzella, A., d’Ischia, M., Napolitano, A., Misuraca, G., & Prota, G. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970099t · Cited by 133 · see citing works

Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.

Jellinger, K. A., Linert, L., Kienzl, E., Herlinger, E., & Youdim, M. B. H. (1995) · PubMed · Cited by 121 · see citing works

Endometrial Pinopodes and Uterine Receptivity

Nikas, G., & Makrigiannakis, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.042 · Cited by 115 · see citing works

Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity

Choi, J., Jang, E.-H., Park, C., & Kang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.008 · Cited by 98 · see citing works

HSP25 protects skeletal muscle cells against oxidative stress

Escobedo, J., Pucci, A. M., & Koh, T. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.024 · Cited by 92 · see citing works

Intersection between metabolic dysfunction, high fat diet consumption, and brain aging

Uranga, R. M., Bruce‐Keller, A. J., Morrison, C. D., Fernandez‐Kim, S. O., Ebenezer, P. J., Zhang, L., Dasuri, K., & Keller, J. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06803.x · Cited by 87 · see citing works

Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins

Gupte, A. A., Bomhoff, G. L., & Geiger, P. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00148.2008 · Cited by 87 · see citing works

Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease

Yokoyama, H., Kuroiwa, H., Yano, R., & Araki, T. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0986-2 · Cited by 85 · see citing works

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l -Dopa1

BOYD, A. E., Lebovitz, H. E., & Feldman, J. M. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-829 · Cited by 84 · see citing works

Effect of a High‐fat Diet on 24‐Hour Pattern of Circulating Adipocytokines in Rats

Cano, P., Cardinali, D. P., Ríos-Lugo, M. J., Fernández‐Mateos, P., Toso, C. F. R., & Esquifino, A. I. (2009) · Obesity · doi:10.1038/oby.2009.200 · Cited by 82 · see citing works

Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease

Morris, J. K., Zhang, H., Gupte, A. A., Bomhoff, G. L., Stanford, J. A., & Geiger, P. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.089 · Cited by 79 · see citing works

Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats

Gupte, A. A., Bomhoff, G. L., Morris, J. K., Gorres, B. K., & Geiger, P. C. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91210.2008 · Cited by 78 · see citing works

Glucose intolerance in parkinson's disease

Lipman, I. J., Boykin, M. E., & Flora, R. E. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90031-9 · Cited by 68 · see citing works

Genetic Basis for Resistance to Parathyroid Hormone

Levine, M. A., Germain‐Lee, E. L., & de Beur, S. M. J. (2003) · Hormone Research in Paediatrics · doi:10.1159/000074508 · Cited by 63 · see citing works

A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload

Chess, D. J., Khairallah, R. J., O’Shea, K. M., Xu, W., & Stanley, W. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00599.2009 · Cited by 57 · see citing works

Evidence for a Novel Set of Small Heat-Shock Proteins That Associates with the Mitochondria of Murine PC12 Cells and Protects NADH:Ubiquinone Oxidoreductase from Heat and Oxidative Stress

Downs, C. A., Jones, L. R., & Heckathorn, S. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1177 · Cited by 53 · see citing works

High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats

Fachinetto, R., Bürger, M. E., WAGNER, C., Wondracek, D. C., Brito, V. B., Nogueira, C. W., FERREIRA, J., & da Rocha, J. B. T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.05.001 · Cited by 40 · see citing works

Acute locomotor effects of fluoxetine, sertraline, and nomifensine in young versus aged Fischer 344 rats

Stanford, J. A., Thomas, T. C., & Gerhardt, G. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00655-4 · Cited by 36 · see citing works

l-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation

Borah, A., & Mohanakumar, K. P. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.11.008 · Cited by 29 · see citing works

[Clinical experience with tolbutamide in Parkinson's disease].

Barbeau, A., GIGUERE, R., & Hardy, J. (1961) · PubMed · Cited by 17 · see citing works

Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000411 · Cited by 2,677 · see citing works

Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019Preprint

du Sert, N. P., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/703355 · Cited by 557 · see citing works

Energy intake and exercise as determinants of brain health and vulnerability to injury and disease

Mattson, M. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.012 · Cited by 434 · see citing works

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · see citing works

Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases

Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 372 · see citing works

Insulin resistance and Parkinson’s disease: A new target for disease modification?

Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

Athauda, D. S., Gulyani, S., Karnati, H. K., Li, Y., Tweedie, D., Mustapić, M., Chawla, S., Chowdhury, K., Skene, S. S., Greig, N. H., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4304 · Cited by 259 · see citing works

Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance

Lu, M., Su, C., Qiao, C., Bian, Y., Ding, J., & Hu, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw047 · Cited by 252 · see citing works

Shared dysregulated pathways lead to Parkinson's disease and diabetes

Santiago, J. A., & Potashkin, J. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.01.002 · Cited by 226 · see citing works

The emerging role of nutrition in Parkinson's disease

Seidl, S. E., Santiago, J. A., Bilyk, H. T., & Potashkin, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00036 · Cited by 209 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

Dai, L., Zou, L. B., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 195 · see citing works

Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration

Spielman, L. J., Little, J. P., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.004 · Cited by 182 · see citing works

Melatonin Regulates Aging and Neurodegeneration through Energy Metabolism, Epigenetics, Autophagy and Circadian Rhythm Pathways

Jenwitheesuk, A., Nopparat, C., Mukda, S., Wongchitrat, P., & Govitrapong, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916848 · Cited by 161 · see citing works

Insulin resistance impairs nigrostriatal dopamine function

Morris, J. K., Bomhoff, G. L., Gorres, B. K., Davis, V. A., Kim, J., Lee, P., Brooks, W. M., Gerhardt, G. A., Geiger, P. C., & Stanford, J. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.005 · Cited by 150 · see citing works

Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study

Nam, G. E., Kim, S. M., Han, K., Kim, N. H., Chung, H. S., Kim, J. W., Han, B., Cho, S.-J., Yu, J. H., Park, Y. G., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002640 · Cited by 148 · see citing works

G lycation in P arkinson's disease and Alzheimer's disease

Miranda, H. V., El‐Agnaf, O. M. A., & Outeiro, T. F. (2016) · Movement Disorders · doi:10.1002/mds.26566 · Cited by 142 · see citing works

Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling

Hong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells · doi:10.3390/cells9030740 · Cited by 133 · see citing works

Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 121 · see citing works

PGC−1α Promoter Methylation in Parkinson’s Disease

Su, L., Chu, Y., Kordower, J. H., Li, B., Cao, H., Huang, L., Nishida, M., Song, L., Wang, D., & Federoff, H. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134087 · Cited by 116 · see citing works

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk

Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 116 · see citing works

The Relevance of Insulin Action in the Dopaminergic System

Fiory, F., Perruolo, G., Cimmino, I., Cabaro, S., Pignalosa, F. C., Miele, C., Bèguinot, F., Formisano, P., & Oriente, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00868 · Cited by 114 · see citing works

Altered Gut Microbiota in Parkinson’s Disease Patients/Healthy Spouses and Its Association with Clinical Features

Zhang, F., Yue, L., Fang, X., Wang, G., Li, C., Sun, X., Jia, X., Yang, J., Song, J., Zhang, Y., et al. (2020) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2020.10.034 · Cited by 111 · see citing works

Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders

Vasconcelos, A. R., dos Santos, N. B., Scavone, C., & Munhoz, C. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00033 · Cited by 112 · see citing works

High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice

Bousquet, M., St‐Amour, I., Vandal, M., Julien, P., Cicchetti, F., & Calon, F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.009 · Cited by 110 · see citing works

Dietary Factors in the Etiology of Parkinson’s Disease

Ağım, Z. S., & Cannon, J. R. (2015) · BioMed Research International · doi:10.1155/2015/672838 · Cited by 107 · see citing works

Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases

Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 107 · see citing works

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Mazucanti, C. H., Cabral‐Costa, J. V., Vasconcelos, A. R., Andreotti, D. Z., Scavone, C., & Kawamoto, E. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 102 · see citing works

Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease

Athauda, D. S., & Foltynie, T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.023 · Cited by 97 · see citing works

PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease

Mouton‐Liger, F., Jacoupy, M., Corvol, J., & Corti, O. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00120 · Cited by 97 · see citing works

Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases

Hölscher, C. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140016 · Cited by 96 · see citing works

System-based approaches to decode the molecular links in Parkinson's disease and diabetes

Santiago, J. A., & Potashkin, J. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.019 · Cited by 85 · see citing works

Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis

Fang, X. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1096271 · Cited by 84 · see citing works

The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases

Cheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84 · see citing works

PGC-1s in the Spotlight with Parkinson’s Disease

Piccinin, E., Sardanelli, A. M., Seibel, P., Moschetta, A., Cocco, T., & Villani, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073487 · Cited by 83 · see citing works

Metabolic Syndrome: An Important Risk Factor for Parkinson’s Disease

Zhang, P., & Tian, B. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/729194 · Cited by 84 · see citing works

Mitochondrial control of cell bioenergetics in Parkinson’s disease

Requejo-Aguilar, R., & Bolaños, J. P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.012 · Cited by 85 · see citing works

Neuroprotective effects of leptin in the context of obesity and metabolic disorders

Davis, C., Mudd, J., & Hawkins, M. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.012 · Cited by 83 · see citing works

Relationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View

Martín-Jiménez, C., Gaitán-Vaca, D. M., Echeverrı́a, V., González, J., & Barreto, G. E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0193-8 · Cited by 77 · see citing works

The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives

Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 83 · see citing works

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases

Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77 · see citing works

Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration

Ramsay, R. R., Májeková, M., Medina, M., & Valoti, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00375 · Cited by 74 · see citing works

Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases

Pistollato, F., & Battino, M. A. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.07.012 · Cited by 71 · see citing works

Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein

Griffioen, K. J. S., Rothman, S. M., Ladenheim, B., Wan, R., Vranis, N. M., Hutchison, E. R., Okun, E., Cadet, J. L., & Mattson, M. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.008 · Cited by 68 · see citing works

Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease

Chen, S., Yu, S., Li, Y., Lecca, D., Glotfelty, E. J., Kim, H. K., Choi, H., Hoffer, B. J., Greig, N. H., Kim, D. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28449-z · Cited by 68 · see citing works

Regulation of Hippocampal Synaptic Function by the Metabolic Hormone, Leptin: Implications for Health and Neurodegenerative Disease

McGregor, G., & Harvey, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00340 · Cited by 67 · see citing works

Insulin Receptor Substrate 2 Expression and Involvement in Neuronal Insulin Resistance in Diabetic Neuropathy

Grote, C. W., Morris, J. K., Ryals, J. M., Geiger, P. C., & Wright, D. E. (2011) · Experimental Diabetes Research · doi:10.1155/2011/212571 · Cited by 66 · see citing works

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease

Song, J., & Kim, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00065 · Cited by 66 · see citing works

Augmenting brain metabolism to increase macro- and chaperone-mediated autophagy for decreasing neuronal proteotoxicity and aging

Loos, B., Klionsky, D. J., & Wong, E. S. P. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.001 · Cited by 61 · see citing works

Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes

Cheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 62 · see citing works

Cholesterol – A putative endogenous contributor towards Parkinson's disease

Paul, R. K., Choudhury, A., & Borah, A. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.025 · Cited by 61 · see citing works

Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones

(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58 · see citing works

High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease

Elabi, O. F., da Cunha, J. P. M. C. M., Gaceb, A., Fex, M., & Paul, G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02218-8 · Cited by 58 · see citing works

The Effects of Leptin on Glial Cells in Neurological Diseases

Fujita, Y., & Yamashita, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00828 · Cited by 54 · see citing works

High-fat diet and neuroinflammation: The role of mitochondria

Song, M., Bai, Y., & Song, F. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107615 · Cited by 54 · see citing works

Adult obese mice suffer from chronic secondary brain injury after mild TBI

Sherman, M., Liu, M., Birnbaum, S. G., Wolf, S. E., Minei, J. P., & Gatson, J. W. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0641-4 · Cited by 53 · see citing works

High-Fat Diet-Induced Weight Gain, Behavioral Deficits, and Dopamine Changes in Young C57BL/6J Mice

Han, J., Nepal, P., Odelade, A. E., Freely, F. D., Belton, D. M., Graves, J. L., & Maldonado‐Devincci, A. M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.591161 · Cited by 51 · see citing works

Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease

Yang, X., Feng, P., Ji, R., Ren, Y., Wei, W., & Hölscher, C. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2079492 · Cited by 51 · see citing works

Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment

Yu, H., Sun, T., He, X., Wang, Z., Zhao, K., An, J., Wen, L., Li, J., Li, W., & Feng, J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0325 · Cited by 51 · see citing works

Parkinson’s Disease: Exploring Different Animal Model Systems

Khan, E., Hasan, I., & Haque, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109088 · Cited by 53 · see citing works

Docosahexaenoic acid-acylated astaxanthin ester exhibits superior performance over non-esterified astaxanthin in preventing behavioral deficits coupled with apoptosis in MPTP-induced mice with Parkinson's disease

Wang, C., Shi, H.-H., Xu, J., Yanagita, T., Xue, C., Zhang, T., & Wang, Y. (2020) · Food & Function · doi:10.1039/d0fo01176b · Cited by 49 · see citing works

Short-term high-fat feeding exacerbates degeneration in retinitis pigmentosa by promoting retinal oxidative stress and inflammation

Kutsyr, O., Noailles, A., Martínez‐Gil, N., Maestre‐Carballa, L., Martínez‐García, M., Maneu, V., Cuenca, N., & Lax, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100566118 · Cited by 46 · see citing works

Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear Craving

Haas, J., Berg, D., Bosy‐Westphal, A., & Schaeffer, E. (2022) · Nutrients · doi:10.3390/nu14153240 · Cited by 46 · see citing works

The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease

Li, H., Zeng, F., Huang, C., Pu, Q., Thomas, E. R., Chen, Y., & Li, X. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14411 · Cited by 45 · see citing works

DA5‐CH and Semaglutide Protect against Neurodegeneration and Reduce α‐Synuclein Levels in the 6‐OHDA Parkinson’s Disease Rat Model

Zhang, L., Li, C., Zhang, Z., Zhang, Z., Jin, Q., Li, L., & Hölscher, C. (2022) · Parkinson s Disease · doi:10.1155/2022/1428817 · Cited by 43 · see citing works

High fat diet-induced obesity causes a reduction in brain tyrosine hydroxylase levels and non-motor features in rats through metabolic dysfunction, neuroinflammation and oxidative stress

Bittencourt, A., Brum, P. O., Ribeiro, C. T., Gasparotto, J., Bortolin, R. C., de Vargas, A. R., Heimfarth, L., de Almeida, R. F., Moreira, J. C. F., de Oliveira, J., et al. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1831261 · Cited by 43 · see citing works

A comparative study about EPA-PL and EPA-EE on ameliorating behavioral deficits in MPTP-induced mice with Parkinson’s disease by suppressing oxidative stress and apoptosis

Wang, C., Wang, D., Zhang, T., Yanagita, T., Xue, C., Chang, Y., & Wang, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.027 · Cited by 42 · see citing works

Glycation, glycolysis, and neurodegenerative diseases: Is there any connection?

Muronetz, V. I., Melnikova, A. K., Seferbekova, Z., Barinova, K. V., & Schmalhausen, E. V. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917080028 · Cited by 41 · see citing works

Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson’s Disease

Miranda‐Díaz, A. G., García-Sánchez, A., & Cardona-Muñóz, E. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6281454 · Cited by 48 · see citing works

Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat

Zengin-Toktas, Y., Authier, N., Denizot, H., Chassain, C., Hafidi, A., Llorca, P., & Durif, F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.011 · Cited by 39 · see citing works

The effects of a high-fat sucrose diet on functional outcome following cortical contusion injury in the rat

Hoane, M. R., Swan, A. A., & Heck, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.028 · Cited by 39 · see citing works

Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease

Miller, O. G., Behring, J. B., Siedlak, S. L., Jiang, S., Matsui, R., Bachschmid, M. M., Zhu, X., & Mieyal, J. J. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6598 · Cited by 38 · see citing works

High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats

Sharma, S., & Taliyan, R. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.025 · Cited by 36 · see citing works

Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention

Fakih, W., Zeitoun, R., AlZaim, I., Eid, A. H., Kobeissy, F. H., Abd‐Elrahman, K. S., & EL‐Yazbi, A. F. (2022) · Obesity · doi:10.1002/oby.23400 · Cited by 36 · see citing works

Hemiballism-hemichorea induced by ketotic hyperglycemia: case report with PET study and review of the literature

Tan, Y., Xin, X., Xiao, Q., Chen, S., Cao, L. H., & Tang, H. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-14 · Cited by 36 · see citing works

HttQ111/+ Huntington’s Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction

Kovalenko, M. V., Milnerwood, A. J., Giordano, J. V., Claire, J. S., Guide, J. R., Stromberg, M., Gillis, T., Sapp, E., DiFiglia, M., MacDonald, M. E., et al. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170282 · Cited by 35 · see citing works

Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats

Nuckolls, A. L., Worley, C., Leto, C., Zhang, H., Morris, J. K., & Stanford, J. A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.003 · Cited by 34 · see citing works

Targeting metabolic inflammation in Parkinson’s disease: Implications for prospective therapeutic strategies

Lu, M., & Hu, G. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05650.x · Cited by 33 · see citing works

Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration

Awamlh, S. A. H. A., Wareham, L. K., Risner, M. L., & Calkins, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094672 · Cited by 30 · see citing works

A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study

Raider, K. D., Ma, D., Harris, J. L., Fuentes, I. M., Rogers, R. S., Wheatley, J. L., Geiger, P. C., Yeh, H., Choi, I.-Y., Brooks, W. M., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.008 · Cited by 27 · see citing works

Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis

Chu, C., Yu, L., Chen, W., Tian, F., & Zhai, Q. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.07.004 · Cited by 26 · see citing works

Current Perspectives: Obesity and Neurodegeneration - Links and Risks

Kueck, P. J., Morris, J. K., & Stanford, J. A. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s388579 · Cited by 29 · see citing works

Brain metabolism as a modulator of autophagy in neurodegeneration.

Lim, Y., Cho, H., & Kim, E.-K. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.049 · Cited by 25 · see citing works

Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice

Rothman, S. M., Griffioen, K. J. S., Fishbein, K. W., Spencer, R. G. S., Makrogiannis, S. K., Cong, W., Martin, B., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.088 · Cited by 26 · see citing works

Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment

Lee, D., Jo, M. G., Kim, S. Y., Chung, C. G., & Lee, S. B. (2020) · Antioxidants · doi:10.3390/antiox9111056 · Cited by 24 · see citing works

Dysmetabolism and Neurodegeneration: Trick or Treat?

Capucho, A. M., Chegão, A., Martins, F. O., Miranda, H. V., & Conde, S. V. (2022) · Nutrients · doi:10.3390/nu14071425 · Cited by 24 · see citing works

Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases

Shen, J., Wang, X., Wang, M., & Zhang, H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1337442 · Cited by 25 · see citing works

Comparing the Effects of Melatonin with Caloric Restriction in the Hippocampus of Aging Mice: Involvement of Sirtuin1 and the FOXOs Pathway

Jenwitheesuk, A., Park, S., Wongchitrat, P., Tocharus, J., Mukda, S., Shimokawa, I., & Govitrapong, P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2369-7 · Cited by 24 · see citing works

GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies

Vaccari, C., Grotto, D., Pereira, T. D. V., de Camargo, J. L. V., & Lopes, L. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255726 · Cited by 23 · see citing works

Actions and Consequences of Insulin in the Striatum

Patel, J. C., Carr, K. D., & Rice, M. E. (2023) · Biomolecules · doi:10.3390/biom13030518 · Cited by 23 · see citing works

Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats

Ma, D., Shuler, J. M., Raider, K. D., Rogers, R. S., Wheatley, J. L., Geiger, P. C., & Stanford, J. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.053 · Cited by 21 · see citing works

Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats

Morris, J. K., Seim, N. B., Bomhoff, G. L., Geiger, P. C., & Stanford, J. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.027 · Cited by 21 · see citing works

Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities

Faizan, M., Sarkar, A., & Singh, M. P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101727 · Cited by 20 · see citing works

Towards New Therapies for Parkinson's Disease

Finkelstein, D. I. (2011) · InTech eBooks · doi:10.5772/954 · Cited by 19 · see citing works

The exposome from neurodevelopment to neurodegeneration: A narrative review

Dallere, S., Rasà, D. M., Pavarino, G., Schellino, R., Vercelli, A., & Boido, M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106247 · Cited by 19 · see citing works

Stearic Acid Supplementation in High Protein to Carbohydrate (P:C) Ratio Diet Improves Physiological and Mitochondrial Functions of Drosophila melanogaster parkin Null Mutants

Bajracharya, R., Bustamante, S., & Ballard, J. W. O. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx246 · Cited by 18 · see citing works

Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development

CAVALCANTI, S. A. D. Q., de Almeida, L. A., & Gasparotto, J. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578171 · Cited by 16 · see citing works

Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson’s disease

Ay, M., Charli, A., Langley, M. R., Jang, A.-Y., Padhi, P., Jin, H., Anantharam, V., Kalyanaraman, B., Kanthasamy, A., & Kanthasamy, A. G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1356703 · Cited by 16 · see citing works

Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia

Shabir, O., Moll, T., Matuszyk, M. M., Eyre, B., Dake, M. D., Berwick, J., & Francis, S. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111361 · Cited by 17 · see citing works

Nigrostriatal Dopmaine Function and Insulin Resistance

Morris, J. K. (2011) · KU ScholarWorks (University of Kansas)

High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats

Sharma, S., & Taliyan, R. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.025 · Cited by 36 · see citing works

Insulin resistance impairs nigrostriatal dopamine function

Morris, J. K., Bomhoff, G. L., Gorres, B. K., Davis, V. A., Kim, J., Lee, P., Brooks, W. M., Gerhardt, G. A., Geiger, P. C., & Stanford, J. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.005 · Cited by 150 · see citing works

High fat diet feeding exacerbates the toxic effects of 6-hydroxydopamine in rats: Possible involvement of histone acetylation

Sharma, S., & Taliyan, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.454 · Cited by 1 · see citing works

Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats

Ma, D., Shuler, J. M., Raider, K. D., Rogers, R. S., Wheatley, J. L., Geiger, P. C., & Stanford, J. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.053 · Cited by 21 · see citing works